Business Description
Oncolys BioPharma Inc
ISIN : JP3202170001
Description
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.86 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | -0.16 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 10.45 | |||||
| Beneish M-Score | -1.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -45.5 | |||||
| 3-Year EBITDA Growth Rate | 9.2 | |||||
| 3-Year EPS without NRI Growth Rate | 5.5 | |||||
| 3-Year FCF Growth Rate | 9.6 | |||||
| 3-Year Book Growth Rate | -18.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.41 | |||||
| 9-Day RSI | 52.8 | |||||
| 14-Day RSI | 54 | |||||
| 6-1 Month Momentum % | 14.55 | |||||
| 12-1 Month Momentum % | -1.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.17 | |||||
| Quick Ratio | 5.15 | |||||
| Cash Ratio | 4.05 | |||||
| Days Inventory | 131.73 | |||||
| Days Sales Outstanding | 640.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.3 | |||||
| Shareholder Yield % | 0.65 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.55 | |||||
| Operating Margin % | -3061.63 | |||||
| Net Margin % | -3075.14 | |||||
| FCF Margin % | -2129.84 | |||||
| ROE % | -119.94 | |||||
| ROA % | -91.31 | |||||
| ROIC % | -334.97 | |||||
| ROC (Joel Greenblatt) % | -476.08 | |||||
| ROCE % | -107.54 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 191.76 | |||||
| PB Ratio | 9.29 | |||||
| Price-to-Tangible-Book | 9.29 | |||||
| EV-to-EBIT | -6.67 | |||||
| EV-to-EBITDA | -6.67 | |||||
| EV-to-Revenue | 204.29 | |||||
| EV-to-FCF | -9.59 | |||||
| Price-to-Median-PS-Value | 4.69 | |||||
| Price-to-Net-Current-Asset-Value | 9.86 | |||||
| Price-to-Net-Cash | 14.18 | |||||
| Earnings Yield (Greenblatt) % | -14.99 | |||||
| FCF Yield % | -9.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oncolys BioPharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 63.038 | ||
| EPS (TTM) (円) | -108.92 | ||
| Beta | 0.86 | ||
| Volatility % | 51.74 | ||
| 14-Day RSI | 54 | ||
| 14-Day ATR (円) | 34.679405 | ||
| 20-Day SMA (円) | 696.55 | ||
| 12-1 Month Momentum % | -1.76 | ||
| 52-Week Range (円) | 504 - 798 | ||
| Shares Outstanding (Mil) | 20.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oncolys BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oncolys BioPharma Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oncolys BioPharma Inc Frequently Asked Questions
What is Oncolys BioPharma Inc(TSE:4588)'s stock price today?
The current price of TSE:4588 is 円698.00. The 52 week high of TSE:4588 is 円798.00 and 52 week low is 円504.00.
When is next earnings date of Oncolys BioPharma Inc(TSE:4588)?
The next earnings date of Oncolys BioPharma Inc(TSE:4588) is .
Does Oncolys BioPharma Inc(TSE:4588) pay dividends? If so, how much?
Oncolys BioPharma Inc(TSE:4588) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers